Volume 22, Issue 3, Pages (March 2015)

Slides:



Advertisements
Similar presentations
MRI-Based Detection of Alkaline Phosphatase Gene Reporter Activity Using a Porphyrin Solubility Switch  Gil G. Westmeyer, Yelena Emer, Jutta Lintelmann,
Advertisements

Rifampicin Inhibits α-Synuclein Fibrillation and Disaggregates Fibrils
Volume 21, Issue 3, Pages (March 2013)
Volume 12, Issue 1, Pages (January 2005)
Volume 112, Issue 12, Pages (June 2017)
Chang-Chun Lee, Yen Sun, Huey W. Huang  Biophysical Journal 
Structure and Dynamics of the Membrane-Bound Form of Pf1 Coat Protein: Implications of Structural Rearrangement for Virus Assembly  Sang Ho Park, Francesca.
Volume 12, Issue 7, Pages (July 2005)
Volume 23, Issue 10, Pages (October 2015)
Thomas E. Edwards, Bruce H. Robinson, Snorri Th. Sigurdsson 
Light-Mediated Inhibition of Protein Synthesis
Volume 13, Issue 5, Pages (May 2005)
Volume 19, Issue 8, Pages (August 2012)
Volume 106, Issue 12, Pages (June 2014)
Volume 17, Issue 3, Pages (March 2009)
Volume 21, Issue 11, Pages (November 2014)
Highly Efficient Self-Replicating RNA Enzymes
MRI-Based Detection of Alkaline Phosphatase Gene Reporter Activity Using a Porphyrin Solubility Switch  Gil G. Westmeyer, Yelena Emer, Jutta Lintelmann,
Volume 19, Issue 7, Pages (July 2012)
Volume 31, Issue 6, Pages (September 2008)
Redesign of a Dioxygenase in Morphine Biosynthesis
Volume 19, Issue 8, Pages (August 2012)
Volume 18, Issue 10, Pages (October 2011)
Volume 13, Issue 2, Pages (February 2005)
Volume 102, Issue 3, Pages (February 2012)
Volume 101, Issue 7, Pages (October 2011)
Structure-Guided Design of Fluorescent S-Adenosylmethionine Analogs for a High- Throughput Screen to Target SAM-I Riboswitch RNAs  Scott F. Hickey, Ming C.
Volume 14, Issue 10, Pages (October 2007)
Volume 13, Issue 1, Pages (January 2006)
A Solution to Limited Genomic Capacity: Using Adaptable Binding Surfaces to Assemble the Functional HIV Rev Oligomer on RNA  Matthew D. Daugherty, Iván.
Volume 21, Issue 5, Pages (May 2014)
Beena Krishnan, Lila M. Gierasch  Chemistry & Biology 
Volume 97, Issue 1, Pages (July 2009)
Fiber-Dependent and -Independent Toxicity of Islet Amyloid Polypeptide
A Subdomain Swap Strategy for Reengineering Nonribosomal Peptides
Volume 23, Issue 5, Pages (May 2015)
Volume 22, Issue 1, Pages (January 2015)
Volume 19, Issue 5, Pages (May 2012)
Structural Basis of Prion Inhibition by Phenothiazine Compounds
Volume 17, Issue 11, Pages (November 2010)
Volume 20, Issue 1, Pages (January 2013)
Volume 12, Issue 1, Pages (January 2005)
Volume 23, Issue 10, Pages (October 2015)
Volume 17, Issue 11, Pages (November 2010)
Volume 19, Issue 1, Pages (January 2011)
Cyclic N-Terminal Loop of Amylin Forms Non Amyloid Fibers
Volume 11, Issue 1, Pages (January 2004)
An Electrophoretic Mobility Shift Assay Identifies a Mechanistically Unique Inhibitor of Protein Sumoylation  Yeong Sang Kim, Katelyn Nagy, Samantha Keyser,
Volume 22, Issue 8, Pages (August 2015)
Volume 22, Issue 2, Pages (February 2015)
Cholesterol Modulates the Dimer Interface of the β2-Adrenergic Receptor via Cholesterol Occupancy Sites  Xavier Prasanna, Amitabha Chattopadhyay, Durba.
Protein Misfolded Oligomers: Experimental Approaches, Mechanism of Formation, and Structure-Toxicity Relationships  Francesco Bemporad, Fabrizio Chiti 
Volume 30, Issue 5, Pages (May 2009)
The Role of Cholesterol in Driving IAPP-Membrane Interactions
Richard D. Perrins, Giuseppe Cecere, Ian Paterson, Gerard Marriott 
Mutational analysis of designed peptides that undergo structural transition from α helix to β sheet and amyloid fibril formation  Yuta Takahashi, Akihiko.
Volume 18, Issue 4, Pages (April 2011)
Morgan E. DeSantis, James Shorter  Chemistry & Biology 
Volume 19, Issue 8, Pages (August 2012)
A Universal Screening Assay for Glycosynthases: Directed Evolution of Glycosynthase XynB2(E335G) Suggests a General Path to Enhance Activity  Alon Ben-David,
Volume 13, Issue 1, Pages (January 2006)
David Jung, Annett Rozek, Mark Okon, Robert E.W Hancock 
Volume 27, Issue 7, Pages e5 (July 2019)
Volume 16, Issue 9, Pages (September 2009)
Volume 25, Issue 9, Pages e3 (September 2017)
Jianchao Li, Haiyang Liu, Manmeet H. Raval, Jun Wan, Christopher M
Volume 114, Issue 4, Pages (February 2018)
Volume 21, Issue 3, Pages (March 2014)
Binding Specificity of Retinal Analogs to Photoactivated Visual Pigments Suggest Mechanism for Fine-Tuning GPCR-Ligand Interactions  Sundaramoorthy Srinivasan,
Volume 100, Issue 5, Pages (March 2011)
Presentation transcript:

Volume 22, Issue 3, Pages 369-378 (March 2015) Islet Amyloid-Induced Cell Death and Bilayer Integrity Loss Share a Molecular Origin Targetable with Oligopyridylamide-Based α-Helical Mimetics  Sunil Kumar, Diana E. Schlamadinger, Mark A. Brown, Joanna M. Dunn, Brandon Mercado, James A. Hebda, Ishu Saraogi, Elizabeth Rhoades, Andrew D. Hamilton, Andrew D. Miranker  Chemistry & Biology  Volume 22, Issue 3, Pages 369-378 (March 2015) DOI: 10.1016/j.chembiol.2015.01.006 Copyright © 2015 Elsevier Ltd Terms and Conditions

Chemistry & Biology 2015 22, 369-378DOI: (10. 1016/j. chembiol. 2015 Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 1 Schematic of Molecules Used in this Work (A) Synthesis of the analogs of tripyridylamide. Reagents and conditions: (a) 33% HBr in AcOH, reflux, 24 hr; (b) 2 M NH3 in EtOH, 0°C for 30 min and then at room temperature for 24 hr; (c) NaNO2, Conc. H2SO4, 0°C for 30 min and then at 0°C for 2 hr; (d) alkyl iodide, Ag2CO3, hexane (dry), 300 W, 120°C, 12 min; (e) Pd(OAc)2, PPh3, dimethylformamide (DMF, dry), methanol (MeOH, dry), triethylamine (Et3N, dry), CO (g), 100°C, 20 hr; (f) LiOH, tetrahydrofuran (THF)/H2O, room temperature, 30 min; (g) Pd/C, H2 (g), THF, room temperature, 4 hr; (h) compound 1-R, 2-chloro-1-methylpyridinium iodide, dichloromethane (DCM, dry), Et3N (dry), reflux, 4 hr; (i) Pd/C, H2 (g), THF, room temperature, 4 hr; (j) compound 2-R, 2-chloro-1-methylpyridinium iodide, DCM (dry), Et3N (dry), reflux, 4 hr; (k) DCM/trifluoroacetic acid (TFA)/triethylsilane (TES) (80:15:5, v/v), room temperature, 3 hr. (B) Structural representations of the analogs of oligopyridylamides. (C) Primary sequence of hIAPP used in the study. (D) A helical wheel representation of the helical subdomain of IAPP. Blue and green represent positively charged and hydrophobic amino acid residues, respectively. Chemistry & Biology 2015 22, 369-378DOI: (10.1016/j.chembiol.2015.01.006) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 2 Effect of Oligopyridylamides on the Kinetics of IAPP Amyloid Assembly (A) Time-dependent ThT fluorescence-based kinetic profiles of lipid-catalyzed IAPP fibrillation alone (black) and in the presence of ADM-1 (blue), IS-5 (brown), or ADM-3 (red) at a ratio of 10:1 (ligand/IAPP). (Inset) A representative sigmoidal fit used to determine the reaction midpoint, t50. (B) Summary of reaction t50 for the effect of analogs of tripyridylamide on the kinetics of lipid-free (black) and lipid-catalyzed (light blue) self-assembly. (C) Dose-dependent effect of ADM-3, ADM-1, ADM-7, and IS-5 on lipid-catalyzed fibrillation. (D) CD spectra of IAPP in the absence and presence of ADM-3 under lipid-containing conditions. (E and F) TEM images of lipid-catalyzed 10 μM IAPP after 1 hr in the absence (E) and presence (F) of ADM-3. Lipid-catalyzed conditions: IAPP = 10 μM, ADM-X = 100 μM, ThT = 5 μM, DOPG/DOPC, 1:1, 100 nm = 630 μM. Lipid-free conditions: IAPP = 40 μM, ADM-X = 40 μM, ThT = 20 μM. For TEM, IAPP = 10 μM, ADM-3 = 10 μM, DOPG/DOPC, 1:1, 100 nm = 630 μM. All error bars represent SDs from a minimum of three repeated measurements. Chemistry & Biology 2015 22, 369-378DOI: (10.1016/j.chembiol.2015.01.006) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 3 Effect of ADM-3 on the Kinetics of Seeded IAPP Fibrillation Representative kinetic profiles of seeded reactions measured under lipid-catalyzed (A) and lipid-free (B) conditions. The x axes are expressed as reaction time divided by the reaction t50 of an unseeded control. (Inset) Statistics of repeats of experiments shown in (A) and (B). For lipid-catalyzed conditions: IAPP = 10 μM, DOPG/DOPC, 1:1, 100 nm = 630 μM, seed = 1% (w/w), ThT = 5 μM. For lipid-free conditions: IAPP = 30 μM, seed = 5% (w/w), ThT = 15 μM. Chemistry & Biology 2015 22, 369-378DOI: (10.1016/j.chembiol.2015.01.006) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 4 Oligopyridylamides Affect IAPP-Mediated Toxicity (A) Representative toxicity of 13 μM IAPP with and without the cointroduction of equimolar amounts of the indicated compound (open bars). Toxicity of 13 μM compound alone (no IAPP) is also shown (filled bars). Error bars reflect variability across 4–8 technical replicates within a single execution of the assay. (B) Statistics of relative toxicity from repeated independent execution of toxicity assays shown in (A). Data are expressed as toxicity in the presence of compound relative to toxicity of IAPP alone measured at the same time on the same batch of cells. (C) Rescue from 13 μM IAPP toxicity as a function of the indicated concentration of ADM-3. Chemistry & Biology 2015 22, 369-378DOI: (10.1016/j.chembiol.2015.01.006) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 5 Attenuation of IAPP-Mediated Liposome Leakage (A) Representative assessment of leakage competence performed using fluorescein dextran-encapsulated liposomes. At t = 0, 200 μM of DOPG LUVs are exposed to the soluble quencher DPX only (control), or with addition of 4 μM IAPP (black), or with addition of 10:1 of the indicated compound/IAPP (colored). The fully leaked response and scale are established with 20 μM magainin 2. (B) Statistics from repeat analysis of single exponential fits to leakage data shown in (A). Data are expressed relative to IAPP only control (black). (Inset) Dose dependence of ADM-3. All error bars represent SDs from a minimum of four repeated measurements. Chemistry & Biology 2015 22, 369-378DOI: (10.1016/j.chembiol.2015.01.006) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 6 Characterization of IAPP Membrane Binding under Alternate Conditions (A and B) CD spectra of 60 μM hIAPP (A) or rat IAPP (B) in the absence (black) and presence (red) of liposomes at the indicated stoichiometry of DOPC/DOPG and with P/L = 1:6.7 (IAPP/lipid). (C) Normalized fluorescence autocorrelation curves for 100 nM rat IAPPRG. Shown are protein alone (black) and in the presence of DOPC/DOPG (3:1) liposomes at the indicated P/L. Shifts of curves to the right are indicative of binding to the liposomes. Red and black are obscured by the green points. (D) NMR (15N HSQC) of 50 μM rat IAPP in the absence (black) or presence (red) of lipid bilayer at 1:6.7 (IAPP/lipid), and DOPC/DOPG at 3:1. (Inset) A 3-fold magnification of resonances from the α-helical subdomain (L12, L16), and the C terminus (Y37). Ellipticity in (A) and (B) are in units of deg cm2 dmol−1 res−1. Buffer conditions (A–C): 20 mM Tris-HCl, 100 mM NaCl (pH 7.4). (D) As in (A–C), but at pH 6.5 here, and pH 7.5 in supplement (Figure S5). Chemistry & Biology 2015 22, 369-378DOI: (10.1016/j.chembiol.2015.01.006) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 7 Atomic Structures of Tripyridylamides (A) A crystallographic dimer of the tert-butyl ester analog of ADM-5. (B) Overlay of crystal structure models of ADM-3 and ADM-7. ADM-3 is derived from the crystal structure of tert-butyl ester ADM-5, with tert-butyl ester and excess R group atoms removed (blue). Crystals were not obtainable for ADM-3. ADM-7 is also shown with tert-butyl ester groups removed. Alignment was performed using only atoms from one of the pyridyl rings. (C) Side-on, space-filled views of the structures shown in (B). (D) Comparison of 1D 1H NMR spectra of the aromatic region (full spectra in Figure S5D) of ADM-3, ADM-5, and ADM-7 under lipid-free, kinetic assay conditions (see Figure 2). Chemistry & Biology 2015 22, 369-378DOI: (10.1016/j.chembiol.2015.01.006) Copyright © 2015 Elsevier Ltd Terms and Conditions